Seeing Is Believing
Currently out of the existing stock ratings of David Evans, 1 are a BUY (100%).
Analyst David Evans works at KEPLER CHEUVREUX with a stock forecast success ratio of 100% fulfilled within 230 days on average.
David Evans’s has documented 2 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVS, Novartis AG ADR at 07-Sep-2022.
Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 9/7/2022. The price target of $92.78 was fulfilled within 230 days with a profit of $22.25 (31.55%) receiving and performance score of 1.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
114
$16.66 (17.12%)
3 months 10 days ago
9/14 (64.29%)
$10.23 (9.86%)
872
Buy
114.85
$17.51 (17.99%)
119
3 months 17 days ago
1/6 (16.67%)
$11.12 (10.72%)
764
Sell
90.02
$-7.32 (-7.52%)
100.71
6 months 10 days ago
4/4 (100%)
$-1.19 (-1.30%)
161
Hold
78.13
$-19.21 (-19.73%)
85.24
6 months 13 days ago
2/3 (66.67%)
$-13.07 (-14.33%)
295
Hold
95.34
$-2 (-2.05%)
6 months 28 days ago
13/13 (100%)
$2.73 (2.95%)
580
What Year was the first public recommendation made by David Evans?